The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector. But, al
The value of data has never been greater in healthcare.
Thanks to constant advances in technology and science, artificial intelligence (AI) is rapidly becoming an integral part of modern healthcare.
MSLs are in prime position to build new structures of engagement as the pharma industry recalibrates after the disruptive force of the pandemic.
Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies.
Editor's Picks
